Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours (QUALINETS)

Ipsen

Status: Completed

Conditions: Gastrointestinal Neuroendocrine Tumours

Study type: Observational

Funder types: Industry

Identifiers

NCT02853422

IPS-ANT- 2015-01 (Other Identifier)

A-ES-52030-351

Details and patient eligibility

About

The purpose of this study is to evaluate the utility of the QLQ-GINET21 in making clinical and therapeutic decisions.

Enrollment: 199 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient with a diagnosis of gastrointestinal endocrine tumour.
• Patient able to read and understand the study questionnaires.
• Patient who has given informed consent in writing to take part in the study.

Exclusion criteria

• Patient who is taking part in another clinical study during the study.
• Patients with another serious malignancy.
• Patients unable to meet the requirements of the protocol (non-compliant patients or those unfit to answer the questionnaires).